Sinopsys Lacrimal Stent Indicated for Sinus Irrigation — SLS  

Ethmoid Sinusitis Clinical Trial

Official title: The Sinopsys Lacrimal Stent Indicated for Sinus Irrigation Via Transcaruncular Ethmoid Sinus Access in Patients With Moderate to Severe Chronic Rhinosinusitis With Ethmoid Sinus Involvement

Status Completed

Clinical Trial Summary

The purpose of this study is to collect preliminary clinical data related to the safety and performance of the Sinopsys Lacrimal Stent.

Clinical Trial Description

For purposes of this clinical study, the Sinopsys Lacrimal Stent is intended to provide a means of administering saline sinus irrigation via a transcaruncular-ethmoid sinus access in patients with moderate to severe chronic rhinosinusitis with ethmoid involvement. The purpose of the administration of saline irrigation is to reduce the intensity of symptoms of chronic rhinosinusitis in this patient population. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Ethmoid Sinusitis

• NCT number: NCT02297243
• Study type: Interventional
• Source: Sinopsys Surgical
• Status: Completed
• Phase: Phase 0
• Start date: March 2015
• Completion date: February 2016